Lorvotuzumab, CAS 339306-30-8

Product Description: Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds CD56 (NCAM1). Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]James I Geller, et al. ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-A Children's Oncology Group study. Cancer. 2020 Dec 15;126(24):5303-5310.

CAS Number: 339306-30-8

Molecular Weight: N/A

Compound Purity: 99.77

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: ADC Antibody

• SKU: MEXHY-P99372-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99372-5
• Green Labware: No
• Package Unit: 5 mg
• Quantity Unit: STK